Comparative studies on drug release from tablets in vitro and its biological availability. II. Biological availability of sodium salicylate from tablets of various formulations
Stozek, T.; Krówczyński, L.; Bohdanowicz, T.
Acta Poloniae Pharmaceutica 40(1): 77-87
1983
ISSN/ISBN: 0001-6837 PMID: 6683923 Document Number: 207973
Document emailed within 1 workday
Related Documents
Northern, R.E.; Lach, J.L.; Fincher, J.H. 1973: Dissolution-dialysis method of assessing in vitro drug availability of prednisolone tablets American Journal of Hospital Pharmacy 30(7): 622-627Ipsen, J. 1971: Mathematical relationship of in vitro release rates and biological availability of controlled-release nitroglycerin (nitrong) Current Therapeutic Research 13(3): 193-208
Lapka, R.; Pospísil, A.; Sedlmayer, P.; Rejholec, V.; Rezanka, V.; Smolík, S.; Franc, Z. 1985: Comparison of the biological availability of retard and non-retard lisuride tablets in dogs Ceskoslovenska Farmacie 34(1): 3-6
Tomassini, L.; Michailova, D.; Naplatanova, D.; Slavtschev, P. 1979: The effects of various factors on the in vitro velocity of drug release from repository tablets. Part 4: Isoniazid (Rimicid) respository tablets Die Pharmazie 34(12): 812-814
Sandell, E.; Eriksson, K.; Mellström, G. 1970: A disintegration test for evaluation of drug availability from tablets and capsules Acta Pharmaceutica Suecica 7(5): 559-566
Terrier, J.L.; Paris, J.; Duchène, D.; Puisieux, F. 1975: Tablets. XV. Influence of Precirol on the in vitro liberation of sodium salicylate. the process of coating the grains Pharmaceutica Acta Helvetiae 50(7-8): 226-231
Shah, S.U.; Shah, K.U.; Rehman, A.; Khan, G.M. 2011: Investigating the in vitro drug release kinetics from controlled release diclofenac potassium-ethocel matrix tablets and the influence of co-excipients on drug release patterns Pakistan Journal of Pharmaceutical Sciences 24(2): 183-192
Chodkowska-Granicka, B.; Pawlak, Z.; Pawlak, E.; Surowiecki, J. 1972: Tablets of 7-(3'-(methylhydroxylethylamino)-2'-hydroxypropyl)-theophylline nicotinate with prolonged action. II. Retardation of the drug release by polymer coating of tablets Acta Poloniae Pharmaceutica 29(6): 618-622
Luckow, V.; Krammer, R.; Traub, R. 1992: Comparative biological availability of two different ibuprofen granules Arzneimittel-Forschung 42(11): 1339-1342
Alderborn, G.; Börjesson, E.; Glazer, M.; Nyström, C. 1988: Studies on direct compression of tablets. XIX. The effect of particle size and shape on the mechanical strength of sodium bicarbonate tablets Acta Pharmaceutica Suecica 25(1): 31-40
Zaremba, M.; Karpińska, B.; Sobaniec, H.; Kacprzak-Wiatr, A.; Grygiel, J.; Konopiński, P.; Zakrzewska, I.; Czeczuga-Semeniuk, E.; Borowski, J. 1984: Studies on the biological availability of vibramycin in humans Acta Poloniae Pharmaceutica 41(6): 695-701
Witchitz, S.; Moisson, P.; Kolsky, H. 1984: A comparative trial of ordinary metoprolol tablets and metoprolol sustained-release tablets in hypertensive patients at rest and on exercise Pharmatherapeutica 3(8): 566-572
Gulde, C.; Voigt, R. 1983: Pharmaceutical and biologic availability of chlorpromazine from macromolecule-containing tablets Die Pharmazie 38(8): 542-546
Sebert, P.; Bardon, J.; Rollet, M.; Robelin, M.N. 1976: Tablets of disulfiram by direct compression: formulation and availability Annales Pharmaceutiques Francaises 34(3-4): 115-122
Eraga, S.O.; Arhewoh, M.I.; Iwuagwu, M.A.; Ukponahiusi, O.E. 2015: Formulation and in vitro release studies of pegylated mucin based matrix tablets Pakistan Journal of Pharmaceutical Sciences 28(1): 113-118
Kaiko, R.F.; Fitzmartin, R.D.; Thomas, G.B.; Goldenheim, P.D. 1992: The bioavailability of morphine in controlled-release 30-mg tablets per rectum compared with immediate-release 30-mg rectal suppositories and controlled-release 30-mg oral tablets PharmacoTherapy 12(2): 107-113
Li, D.-Y.; Liu, X.-Q.; Feng, W.-H.; Wang, Z.-M.; Yi, H.; Meng, Q.-J. 2013: Study on application of bioassay method in drug-release evaluation in vitro of Salvia miltiorrhiza hydrophilic gel matrix tablets Zhongguo Zhong Yao Za Zhi 38(22): 3880-3887
Wierzchowiecki, M.; Swiderczuk, A.; Dyderski, S.; Masiakowski, J.; Jazienicki, B. 1987: Studies of the biological availability of phenytoin preparations (Polfa) and micronized phenytoin in patients with cardiac rhythm disorders Kardiologia Polska 30(9): 577-582
Nyberg, L.; Andersson, K.E.; Bertler, A. 1974: Bioavailability of digoxin from tablets. III. Availability of digoxin in man from preparations with different dissolution rate Acta Pharmaceutica Suecica 11(5): 471-492
Hrishi Keshavan, H.J.; Gurbani, N.K.; Batra, V.; Dandiya, P.C.; Sharma, R.G. 1980: Availability of ampicillin in biological fluids Indian Journal of Medical Research 72: 920-922